AI assistant
Sending…
Microbot Medical Inc. — Director's Dealing 2019
Dec 26, 2019
33819_dirs_2019-12-26_71b670f7-c0c5-4367-9ef6-edece8cbd35f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2019-12-23
Reporting Person: Gadot Harel (Director, Chairman, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-23 | Common Stock, par value $0.01 per share | S | 40000 | $10.00 | Disposed | 136847 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in April 2019.
F2: Does not include any options to purchase common stock owned by the reporting person.
F3: Mr. Gadot is the Chief Executive Officer, Company Group Chairman and majority equity owner of MEDX Venture Group and thus may be deemed to share voting and investment power over the shares beneficially owned by this entity.
More from Microbot Medical Inc.
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 13